Clinical and Angiographic Outcomes in Diabetics From the ENDEAVOR IV Trial

Ajay J. Kirtane,Rikesh Patel,Charles O'Shaughnessy,Paul Overlie,Brent McLaurin,Stuart Solomon,Laura Mauri,Peter Fitzgerald,Jeffrey J. Popma,David E. Kandzari,Martin B. Leon

JACC: Cardiovascular Interventions（2009）

引用 60|浏览19

暂无评分

摘要

Conclusions One-year clinical outcomes were similar among DM patients treated with ZES and PES in the ENDEAVOR IV trial. These findings parallel the overall trial results, which demonstrated similar efficacy and safety of ZES and PES for single de novo coronary lesions.

查看译文

关键词

diabetes mellitus,drug-eluting stent,Endeavor IV,zotarolimus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要